AKT1 and B-cell chronic lymphocytic leukemia: TLR signaling leads to the activation of several downstream signaling pathways, including MAPK/ERK, PI3K/AKT/mTOR, and NF-κB (97), resulting in the activation and proliferation of CLL cells (43) (Figure 2).